Phio Pharmaceuticals Corp [NASDAQ: PHIO] jumped around 0.23 points on Friday, while shares priced at $2.74 at the close of the session, up 9.16%.
Phio Pharmaceuticals Corp stock is now -27.32% down from its year-to-date (YTD) trading value. PHIO Stock saw the intraday high of $3.4799 and lowest of $2.51 per share. The company’s 52-week high price is 9.79, which means current price is +182.47% above from all time high which was touched on 01/13/25.
Compared to the average trading volume of 561.36K shares, PHIO reached a trading volume of 49354844 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Phio Pharmaceuticals Corp [PHIO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PHIO shares is $14.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PHIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Phio Pharmaceuticals Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 05, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on August 05, 2020, representing the official price target for Phio Pharmaceuticals Corp stock.
The Price to Book ratio for the last quarter was 1.08, with the Price to Cash per share for the same quarter was set at 2.77.
How has PHIO stock performed recently?
Phio Pharmaceuticals Corp [PHIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.84. With this latest performance, PHIO shares gained by 26.27% in over the last four-week period, additionally plugging by 17.09% over the last 6 months – not to mention a rise of 52.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PHIO stock in for the last two-week period is set at 65.03, with the RSI for the last a single of trading hit 0.23, and the three-weeks RSI is set at 0.21 for Phio Pharmaceuticals Corp [PHIO]. The present Moving Average for the last 50 days of trading for this stock 2.27, while it was recorded at 2.54 for the last single week of trading, and 2.21 for the last 200 days.
Phio Pharmaceuticals Corp (PHIO) Capital Structure & Debt Analysis
According to recent financial data for Phio Pharmaceuticals Corp. ( PHIO), the Return on Equity (ROE) stands at -76.12%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -66.67%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Phio Pharmaceuticals Corp’s Return on Invested Capital (ROIC) is -55.59%, showcasing its effectiveness in deploying capital for earnings.
Phio Pharmaceuticals Corp (PHIO) Efficiency & Liquidity Metrics
Based on Phio Pharmaceuticals Corp’s (PHIO) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Phio Pharmaceuticals Corp (PHIO) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Phio Pharmaceuticals Corp. (PHIO) effectively leverages its workforce, generating an average of -$1352000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 10.58% and a Quick Ratio of 10.58%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Phio Pharmaceuticals Corp [PHIO]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PHIO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Phio Pharmaceuticals Corp go to 64.39%.
Insider trade positions for Phio Pharmaceuticals Corp [PHIO]
There are presently around $15.77%, or 15.83% of PHIO stock, in the hands of institutional investors.
